Dual CAR-T cell therapy for glioblastoma: strategies to cure tumour diseases based on a mathematical model
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Dual CAR-T cell therapy for glioblastoma: strategies to cure tumour diseases based on a mathematical model ; volume:113 ; number:2 ; day:17 ; month:9 ; year:2024 ; pages:1637-1666 ; date:1.2025
Nonlinear dynamics ; 113, Heft 2 (17.9.2024), 1637-1666, 1.2025
- Creator
-
Bodnar, Marek
Piotrowska, Monika J.
Bodzioch, Mariusz
Belmonte-Beitia, Juan
Foryś, Urszula
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11071-024-10258-x
- URN
-
urn:nbn:de:101:1-2502122217237.272341996804
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bodnar, Marek
- Piotrowska, Monika J.
- Bodzioch, Mariusz
- Belmonte-Beitia, Juan
- Foryś, Urszula
- SpringerLink (Online service)
Other Objects (12)
Engineering CAR-T cells
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
Strategies to enhance CAR-T persistence
Gut microbiome and CAR-T therapy
Target selection for CAR-T therapy
Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma
Oxamate enhances the efficacy of CAR-T therapy against glioblastoma via suppressing ectonucleotidases and CCR8 lactylation
Recent advances in CAR-T cell engineering
CAR-T Cell Therapy for Solid Tumors
New development in CAR-T cell therapy
Application of blood brain barrier models in pre-clinical assessment of glioblastoma-targeting CAR-T based immunotherapies
Antitumor effects of intracranial injection of B7-H3-targeted Car-T and Car-Nk cells in a patient-derived glioblastoma xenograft model
Engineering CAR-T cells
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
Strategies to enhance CAR-T persistence
Gut microbiome and CAR-T therapy
Target selection for CAR-T therapy
Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma
Oxamate enhances the efficacy of CAR-T therapy against glioblastoma via suppressing ectonucleotidases and CCR8 lactylation
Recent advances in CAR-T cell engineering
CAR-T Cell Therapy for Solid Tumors
New development in CAR-T cell therapy
Application of blood brain barrier models in pre-clinical assessment of glioblastoma-targeting CAR-T based immunotherapies
Antitumor effects of intracranial injection of B7-H3-targeted Car-T and Car-Nk cells in a patient-derived glioblastoma xenograft model
Engineering CAR-T cells
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
Strategies to enhance CAR-T persistence
Gut microbiome and CAR-T therapy
Target selection for CAR-T therapy
Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma
Oxamate enhances the efficacy of CAR-T therapy against glioblastoma via suppressing ectonucleotidases and CCR8 lactylation
Recent advances in CAR-T cell engineering
CAR-T Cell Therapy for Solid Tumors
New development in CAR-T cell therapy
Application of blood brain barrier models in pre-clinical assessment of glioblastoma-targeting CAR-T based immunotherapies